These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 35637154)

  • 1. Laparoscopic nephron sparing surgery and radical nephrectomy in cT1 renal tumors. Comparative analysis of complications and survival.
    Luis-Cardo A; Herranz-Amo F; Rodríguez-Cabero M; Quintana-Álvarez R; Esteban Labrador L; Rodríguez-Fernández E; Mayor-de Castro J; Barbas Bernardos G; Ramírez Martín D; Hernández-Fernández C
    Actas Urol Esp (Engl Ed); 2022; 46(6):340-347. PubMed ID: 35637154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of renal function in patients with CT1 renal tumors after laparoscopic partial and radical nephrectomy. Predictive factors for renal function impairment.
    Luis Cardo A; Herranz Amo F; Rodríguez Cabero M; Hernández Cavieres J; Subirá Ríos D; Moralejo Gárate M; Aragón Chamizo J; Barbas Bernardos G; Ramirez Martín D; Hernández Fernández C
    Actas Urol Esp (Engl Ed); 2021 Jul; ():. PubMed ID: 34334242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.
    Attawettayanon W; Kazama A; Yasuda Y; Zhang JJH; Shah S; Rathi N; Munoz-Lopez C; Lewis K; Li J; Beksac AT; Campbell RA; Kaouk J; Haber GP; Weight C; Martin C; Campbell SC
    Ann Surg Oncol; 2024 Mar; 31(3):2133-2143. PubMed ID: 38071719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of partial versus radical nephrectomy for renal cell carcinoma: Is oncologic safety compromised during nephron sparing in higher stage disease?
    Hakam N; Heidar NA; El-Asmar J; Khauli M; Degheili J; Al-Moussawy M; Nasr R; El-Hajj A; Wazzan W; Bulbul M; Khauli RB
    Urol Ann; 2023; 15(2):226-231. PubMed ID: 37304513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study.
    Borregales LD; Pecoraro A; Roussel E; Mari A; Grosso AA; Checcucci E; Montorsi F; Larcher A; Van Poppel H; Porpiglia F; Capitanio U; Minervini A; Albersen M; Serni S; Amparore D; Campi R
    Eur J Surg Oncol; 2023 Oct; 49(10):107014. PubMed ID: 37573666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis.
    Huang R; Zhang C; Wang X; Hu H
    Front Oncol; 2021; 11():680842. PubMed ID: 34178668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer.
    Cei F; Larcher A; Rosiello G; Basile G; Musso G; Re C; Fallara G; Belladelli F; Brembilla G; Guazzarotti G; De Cobelli F; Marandino L; Necchi A; Briganti A; Salonia A; Bertini R; Montorsi F; Capitanio U
    Urol Oncol; 2024 Aug; 42(8):247.e21-247.e27. PubMed ID: 38644109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
    Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
    Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRENDS IN SURGICAL MANAGEMENT OF RENAL NEOPLASMS: SINGLE CENTER RESULTS IN THE LAST DECADE.
    Knežević N; Zekulić T; Kuliš T; Penezić L; Hudolin T; Čikić B; Ferenčak V; Anđelić J; Saić H; Jurić I; El-Saleh A; Goluža E; Kaštelan Ž
    Acta Clin Croat; 2023 Jul; 62(Suppl2):53-59. PubMed ID: 38966023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
    Xing Z; Xu H; Ai K; Deng H; Hong Y; Deng P; Wang J; Xiong W; Li Z; Zhu L; Li Y
    Ann Surg Oncol; 2024 May; 31(5):3531-3543. PubMed ID: 38329657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year healthcare costs after robotic-assisted and laparoscopic partial and radical nephrectomy: a cohort study.
    Okhawere KE; Milky G; Razdan S; Shih IF; Li Y; Zuluaga L; Badani KK
    BMC Health Serv Res; 2023 Oct; 23(1):1099. PubMed ID: 37838666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center study.
    Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Martini A; Tian Z; Karakiewicz PI; Mottrie A; Boarin M; Villa G; Trevisani F; Marandino L; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    Urol Oncol; 2023 Mar; 41(3):149.e17-149.e25. PubMed ID: 36369233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenchymal obliteration by renal masses: Functional and oncologic implications.
    Kazama A; Munoz-Lopez C; Attawettayanon W; Boumitri M; Maina E; Lone Z; Rathi N; Lewis K; Campbell RA; Palacios DA; Kaouk J; Haber GP; Haywood S; Almassi N; Weight CJ; Remer EM; Ward R; Nowacki AS; Campbell SC
    Urol Oncol; 2024 Aug; 42(8):247.e11-247.e19. PubMed ID: 38729867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserving Renal Function without Compromising Oncological Outcomes: A Comparative Study of Partial and Total Nephrectomies in T3 Stage Renal Cell Carcinoma.
    Alasker A; Alnafisah TR; Alghafees M; Shafqat A; Sabbah BN; Alhaider A; Alsayyari A; Althonayan N; AlOtaibi M; Ofisan SB; Alghamdi M; Albogami N; Al-Khayal A
    J Kidney Cancer VHL; 2023; 10(4):28-32. PubMed ID: 38162464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy.
    Ziegelmueller BK; Spek A; Szabados B; Casuscelli J; Buchner A; Stief C; Staehler M
    Cureus; 2019 Sep; 11(9):e5781. PubMed ID: 31723540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing.
    Pietzak EJ; Guzzo TJ
    Adv Urol; 2012; 2012():148952. PubMed ID: 22645606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma.
    Dong W; Chen X; Huang M; Chen X; Gao M; Ou D; Li K; Wang C; Wu S; Liu H; Xie W; Xie W; Campbell SC; Lin T; Huang J
    Front Oncol; 2020; 10():595457. PubMed ID: 33520708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Impact of the Surgical Margin in Renal Cell Carcinoma Treated with Partial Nephrectomy: A Multi-Center Study.
    Mosholt KSS; Aagaard M; Røder A; Azawi N
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672530
    [No Abstract]   [Full Text] [Related]  

  • 19. Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience.
    Brassetti A; Anceschi U; Bove AM; Prata F; Costantini M; Ferriero M; Mastroianni R; Misuraca L; Tuderti G; Torregiani G; Covotta M; Gallucci M; Simone G
    Curr Oncol; 2023 Jan; 30(1):1196-1205. PubMed ID: 36661741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers.
    Siev M; Renson A; Tan HJ; Rose TL; Kang SK; Huang WC; Bjurlin MA
    Kidney Cancer; 2020; 4(1):49-58. PubMed ID: 34084980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.